These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 25695936)

  • 1. Human Bone Marrow Stromal Cells Differentiate Into Corneal Tissue and Prevent Ocular Graft-Versus-Host Disease in Mice.
    Sánchez-Abarca LI; Hernández-Galilea E; Lorenzo R; Herrero C; Velasco A; Carrancio S; Caballero-Velázquez T; Rodríguez-Barbosa JI; Parrilla M; Del Cañizo C; San Miguel J; Aijón J; Pérez-Simón JA
    Cell Transplant; 2015; 24(12):2423-33. PubMed ID: 25695936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inducible Costimulator Gene-Transduced Bone Marrow-Derived Mesenchymal Stem Cells Attenuate the Severity of Acute Graft-Versus-Host Disease in Mouse Models.
    Yang D; Wang LP; Zhou H; Cheng H; Bao XC; Xu S; Zhang WP; Wang JM
    Cell Transplant; 2015; 24(9):1717-31. PubMed ID: 25203502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subconjunctival injection of mesenchymal stromal cells protects the cornea in an experimental model of GVHD.
    Martínez-Carrasco R; Sánchez-Abarca LI; Nieto-Gómez C; Martín García E; Sánchez-Guijo F; Argüeso P; Aijón J; Hernández-Galilea E; Velasco A
    Ocul Surf; 2019 Apr; 17(2):285-294. PubMed ID: 30630121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination cell therapy using mesenchymal stem cells and regulatory T-cells provides a synergistic immunomodulatory effect associated with reciprocal regulation of TH1/TH2 and th17/treg cells in a murine acute graft-versus-host disease model.
    Lim JY; Park MJ; Im KI; Kim N; Jeon EJ; Kim EJ; Cho ML; Cho SG
    Cell Transplant; 2014 Apr; 23(6):703-14. PubMed ID: 23452894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of bone marrow mesenchymal stem cells on hematopoietic recovery and acute graft-versus-host disease in murine allogeneic umbilical cord blood transplantation model.
    Li ZY; Wang CQ; Lu G; Pan XY; Xu KL
    Cell Biochem Biophys; 2014 Sep; 70(1):115-22. PubMed ID: 24696072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of bone marrow-derived mesenchymal stromal cells on experimental xenogeneic graft-versus-host disease.
    Bruck F; Belle L; Lechanteur C; de Leval L; Hannon M; Dubois S; Castermans E; Humblet-Baron S; Rahmouni S; Beguin Y; Briquet A; Baron F
    Cytotherapy; 2013 Mar; 15(3):267-79. PubMed ID: 23265769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of mesenchymal stromal cells from human bone marrow and adipose tissue for the treatment of spinal cord injury.
    Zhou Z; Chen Y; Zhang H; Min S; Yu B; He B; Jin A
    Cytotherapy; 2013 Apr; 15(4):434-48. PubMed ID: 23376106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-culture of human bone marrow mesenchymal stem cells and macrophages attenuates lipopolysaccharide-induced inflammation in human corneal epithelial cells.
    Jeong WY; Kim JH; Kim CW
    Biosci Biotechnol Biochem; 2018 May; 82(5):800-809. PubMed ID: 29452534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced efficacy of mesenchymal stromal cells in preventing graft-versus-host disease in an in vivo model of haploidentical bone marrow transplant with leukemia.
    Oviedo A; Yañez R; Colmenero I; Aldea M; Rubio A; Bueren JA; Lamana ML
    Cell Transplant; 2013; 22(8):1381-94. PubMed ID: 23044223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Placenta-derived mesenchymal stem cells have an immunomodulatory effect that can control acute graft-versus-host disease in mice.
    Jang MJ; Kim HS; Lee HG; Kim GJ; Jeon HG; Shin HS; Chang SK; Hur GH; Chong SY; Oh D; Chung HM
    Acta Haematol; 2013; 129(4):197-206. PubMed ID: 23257958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stromal cells inhibit graft-versus-host disease of mice in a dose-dependent manner.
    Joo SY; Cho KA; Jung YJ; Kim HS; Park SY; Choi YB; Hong KM; Woo SY; Seoh JY; Cho SJ; Ryu KH
    Cytotherapy; 2010 May; 12(3):361-70. PubMed ID: 20078382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow-derived conventional, but not cloned, mesenchymal stem cells suppress lymphocyte proliferation and prevent graft-versus-host disease in rats.
    Kitazawa Y; Li XK; Xie L; Zhu P; Kimura H; Takahara S
    Cell Transplant; 2012; 21(2-3):581-90. PubMed ID: 22793067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Comparative Study of the Therapeutic Potential of Mesenchymal Stem Cells and Limbal Epithelial Stem Cells for Ocular Surface Reconstruction.
    Holan V; Trosan P; Cejka C; Javorkova E; Zajicova A; Hermankova B; Chudickova M; Cejkova J
    Stem Cells Transl Med; 2015 Sep; 4(9):1052-63. PubMed ID: 26185258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine bone marrow derived stromal progenitor cells fail to prevent or treat acute graft-versus-host disease.
    Badillo AT; Peranteau WH; Heaton TE; Quinn C; Flake AW
    Br J Haematol; 2008 Apr; 141(2):224-34. PubMed ID: 18318768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of FGF-2 on collagen tissue regeneration by human vertebral bone marrow stem cells.
    Park DS; Park JC; Lee JS; Kim TW; Kim KJ; Jung BJ; Shim EK; Choi EY; Park SY; Cho KS; Kim CS
    Stem Cells Dev; 2015 Jan; 24(2):228-43. PubMed ID: 25122057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal stem cells home to inflamed ocular surface and suppress allosensitization in corneal transplantation.
    Omoto M; Katikireddy KR; Rezazadeh A; Dohlman TH; Chauhan SK
    Invest Ophthalmol Vis Sci; 2014 Sep; 55(10):6631-8. PubMed ID: 25228546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The negative co-signaling molecule b7-h4 is expressed by human bone marrow-derived mesenchymal stem cells and mediates its T-cell modulatory activity.
    Xue Q; Luan XY; Gu YZ; Wu HY; Zhang GB; Yu GH; Zhu HT; Wang M; Dong W; Geng YJ; Zhang XG
    Stem Cells Dev; 2010 Jan; 19(1):27-38. PubMed ID: 19788399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The immunosuppressive properties of non-cultured dermal-derived mesenchymal stromal cells and the control of graft-versus-host disease.
    Gao L; Liu F; Tan L; Liu T; Chen Z; Shi C
    Biomaterials; 2014 Apr; 35(11):3582-8. PubMed ID: 24468404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal stromal cells from pooled mononuclear cells of multiple bone marrow donors as rescue therapy in pediatric severe steroid-refractory graft-versus-host disease: a multicenter survey.
    Kuçi Z; Bönig H; Kreyenberg H; Bunos M; Jauch A; Janssen JW; Škifić M; Michel K; Eising B; Lucchini G; Bakhtiar S; Greil J; Lang P; Basu O; von Luettichau I; Schulz A; Sykora KW; Jarisch A; Soerensen J; Salzmann-Manrique E; Seifried E; Klingebiel T; Bader P; Kuçi S
    Haematologica; 2016 Aug; 101(8):985-94. PubMed ID: 27175026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics and function of mesenchymal stem cells in corneal injury.
    Lan Y; Kodati S; Lee HS; Omoto M; Jin Y; Chauhan SK
    Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):3638-44. PubMed ID: 22562508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.